{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:24:28Z","timestamp":1782303868571,"version":"3.54.5"},"reference-count":172,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.bbagen.2025.130800","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T05:54:31Z","timestamp":1743746071000},"page":"130800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inhibitors of inflammasome (NLRP3) signaling pathway as promising therapeutic candidates for oral cancer"],"prefix":"10.1016","volume":"1869","author":[{"given":"Shreya","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shatakshi","family":"Narang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadvendra","family":"Shahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayali","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2021","key":"10.1016\/j.bbagen.2025.130800_bb0005","doi-asserted-by":"crossref","first-page":"baab034","DOI":"10.1093\/database\/baab034","article-title":"dbGENVOC: database of GENomic variants of Oral Cancer, with special reference to India","volume":"28","author":"Pradhan","year":"2021","journal-title":"Database (Oxford)"},{"key":"10.1016\/j.bbagen.2025.130800_bb0010","article-title":"Oral cancer diagnosis and perspectives in India","volume":"1","author":"Borse","year":"2020","journal-title":"Sens Int."},{"issue":"9","key":"10.1016\/j.bbagen.2025.130800_bb0015","first-page":"11884","article-title":"Essentials of oral cancer","volume":"8","author":"Rivera","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"6","key":"10.1016\/j.bbagen.2025.130800_bb0020","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1590\/1678-775720140254","article-title":"Oral potentially malignant disorders in a large dental population","volume":"22","author":"Villa","year":"2014","journal-title":"J. Appl. Oral Sci."},{"key":"10.1016\/j.bbagen.2025.130800_bb0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.oraloncology.2016.08.005","article-title":"Single nucleotide polymorphisms as markers of genetic susceptibility for oral potentially malignant disorders risk: review of evidence to date","volume":"61","author":"Shridhar","year":"2016","journal-title":"Oral Oncol."},{"issue":"5","key":"10.1016\/j.bbagen.2025.130800_bb0030","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jcms.2017.01.033","article-title":"Biomarkers in diagnosis and therapy of oral squamous cell carcinoma: a review of the literature","volume":"45","author":"Blatt","year":"2017","journal-title":"J. Craniomaxillofac. Surg."},{"issue":"5","key":"10.1016\/j.bbagen.2025.130800_bb0035","first-page":"401","article-title":"Oral cavity and oropharyngeal squamous cell carcinoma\u2013an update","volume":"65","author":"Chi","year":"2015","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0040","doi-asserted-by":"crossref","first-page":"652","DOI":"10.62110\/sciencein.cbl.2024.v11.652","article-title":"Signaling and molecular pathways implicated in oral cancer: A concise review. Chemical","volume":"11","author":"Kumari","year":"2024","journal-title":"Biol. Lett."},{"issue":"5","key":"10.1016\/j.bbagen.2025.130800_bb0045","first-page":"411","article-title":"Epidemiological and histopathological features of Oral squamous cell carcinoma-A retrospective study","volume":"50","author":"Ilie","year":"2024","journal-title":"Curr. Health Sci. J."},{"key":"10.1016\/j.bbagen.2025.130800_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-017-0589-y","article-title":"NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma","volume":"36","author":"Huang","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0055","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s12885-018-4403-9","article-title":"NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbagen.2025.130800_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1195572","article-title":"The roles of inflammasomes in cancer","volume":"14","author":"Deng","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.bbagen.2025.130800_bb0065","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrclinonc.2015.105","article-title":"Inflammation and cancer: advances and new agents","volume":"12","author":"Crusz","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.bbagen.2025.130800_bb0070","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0075","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12943-018-0900-3","article-title":"Role of the NLRP3 inflammasome in cancer","volume":"17","author":"Moossavi","year":"2018","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.bbagen.2025.130800_bb0080","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016287","article-title":"Inflammasomes","volume":"6","author":"de Zoete","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"10","key":"10.1016\/j.bbagen.2025.130800_bb0085","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.3390\/cancers13102297","article-title":"Targeting the NLRP3 inflammasome as a new therapeutic option for overcoming cancer","volume":"13","author":"Missiroli","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbagen.2025.130800_bb0090","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211034366","article-title":"New approaches and procedures for cancer treatment: current perspectives","volume":"9","author":"Debela","year":"2021","journal-title":"SAGE Open Med."},{"key":"10.1016\/j.bbagen.2025.130800_bb0095","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211034366","article-title":"New approaches and procedures for cancer treatment: current perspectives","volume":"9","author":"Debela","year":"2021","journal-title":"SAGE Open Med."},{"key":"10.1016\/j.bbagen.2025.130800_bb0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.17126\/joralres.2015.003","article-title":"The challenge of the state of susceptibility to oral cancer","volume":"4","author":"Rivera","year":"2015","journal-title":"J. Oral Res."},{"key":"10.1016\/j.bbagen.2025.130800_bb0105","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2147\/CMAR.S351744","article-title":"Technological advancements in external beam radiation therapy (EBRT): an indispensable tool for cancer treatment","volume":"11","author":"Koka","year":"2022","journal-title":"Cancer Manag. Res."},{"issue":"5","key":"10.1016\/j.bbagen.2025.130800_bb0110","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.bbagen.2025.130800_bb0115","first-page":"e11","article-title":"Oral squamous cell carcinoma: early detection and improved 5-year survival in 102 patients","volume":"66","author":"Sciubba","year":"2018","journal-title":"Gen. Dent."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0120","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1038\/s41598-023-29204-9","article-title":"Detection of oral squamous cell carcinoma in clinical photographs using a vision transformer","volume":"13","author":"Fl\u00fcgge","year":"2023","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.bbagen.2025.130800_bb0125","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bbagen.2025.130800_bb0130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.bbagen.2025.130800_bb0135","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/eji.201545523","article-title":"Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells","volume":"45","author":"Gaidt","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.bbagen.2025.130800_bb0140","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.1402321","article-title":"IL-18 triggered by the Nlrp3 inflammasome induces host innate resistance in a pulmonary model of fungal infection","volume":"194","author":"Ketelut-Carneiro","year":"2015","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.bbagen.2025.130800_bb0150","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fphar.2015.00262","article-title":"NLRP3 inflammasome and its inhibitors: a review","volume":"6","author":"Shao","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0155","first-page":"C83","article-title":"NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption: roles for K+ efflux and Ca2+ influx","volume":"311","author":"Katsnelson","year":"2016","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"13","key":"10.1016\/j.bbagen.2025.130800_bb0160","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bbagen.2025.130800_bb0165","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"issue":"8","key":"10.1016\/j.bbagen.2025.130800_bb0170","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.4049\/jimmunol.1402658","article-title":"K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca2+ signaling","volume":"194","author":"Katsnelson","year":"2015","journal-title":"J. Immunol."},{"issue":"14","key":"10.1016\/j.bbagen.2025.130800_bb0175","article-title":"The NLRP3 inflammasome pathway: A review of mechanisms and inhibitors for the treatment of inflammatory diseases","volume":"10","author":"Blevins","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"9","key":"10.1016\/j.bbagen.2025.130800_bb0180","article-title":"NLRP3 inflammasome: A promising therapeutic target for drug-induced toxicity","volume":"12","author":"Wei","year":"2021","journal-title":"Front. Cell Development. Biol."},{"issue":"8","key":"10.1016\/j.bbagen.2025.130800_bb0185","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.4049\/jimmunol.1400582","article-title":"Cytosolic double-stranded RNA activates the NLRP3 inflammasome via MAVS-induced membrane permeabilization and K+ efflux","volume":"193","author":"Franchi","year":"2014","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0190","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12943-018-0900-3","article-title":"Role of the NLRP3 inflammasome in cancer","volume":"17","author":"Moossavi","year":"2018","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0195","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.imlet.2015.03.003","article-title":"Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF \u03baB1","volume":"165","author":"Park","year":"2015","journal-title":"Immunol. Lett."},{"issue":"26","key":"10.1016\/j.bbagen.2025.130800_bb0200","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2123247119","article-title":"Mitochondrial calcium uniporter promotes phagocytosis-dependent activation of the NLRP3 inflammasome","volume":"119","author":"Dong","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbagen.2025.130800_bb0205","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fmicb.2014.00438","article-title":"Mitochondrial ROS potentiates indirect activation of the AIM2 inflammasome","volume":"5","author":"Crane","year":"2014","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0210","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yexcr.2017.11.015","article-title":"Cathepsin B links oxidative stress to the activation of NLRP3 inflammasome","volume":"362","author":"Bai","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"13","key":"10.1016\/j.bbagen.2025.130800_bb0215","doi-asserted-by":"crossref","first-page":"6984","DOI":"10.3390\/ijms22136984","article-title":"NLRP3 and infections: \u03b2-amyloid in Inflammasome beyond neurodegeneration","volume":"22","author":"Sita","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"FEB","key":"10.1016\/j.bbagen.2025.130800_bb0220","article-title":"Malarial pigment hemozoin and the innate inflammatory response","volume":"5","author":"Olivier","year":"2014","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbagen.2025.130800_bb0225","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.4049\/jimmunol.1500509","article-title":"Multiple cathepsins promote pro\u2013IL-1\u03b2 synthesis and NLRP3-mediated IL-1\u03b2 activation","volume":"195","author":"Orlowski","year":"2015","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.bbagen.2025.130800_bb0230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fcell.2020.00167","article-title":"Cathepsin B is required for NLRP3 inflammasome activation in macrophages, through NLRP3 interaction","volume":"31","author":"Chevriaux","year":"2020","journal-title":"Front. Cell Development. Biol."},{"issue":"3","key":"10.1016\/j.bbagen.2025.130800_bb0235","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/cancers13030373","article-title":"Modulation of CD4 T cell response according to tumor cytokine microenvironment","volume":"13","author":"Accogli","year":"2021","journal-title":"Cancers"},{"issue":"20","key":"10.1016\/j.bbagen.2025.130800_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011108","article-title":"NLRP3 Inflammasome inhibitor BAY-117082 reduces Oral squamous cell carcinoma progression","volume":"22","author":"Scuderi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbagen.2025.130800_bb0245","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2015.525","article-title":"Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer","volume":"9","author":"Mishra","year":"2015","journal-title":"Ecancermedicalscience"},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FJC.0000000000000247","article-title":"Pharmacologic inhibition of the NLRP3 inflammasome preserves cardiac function after ischemic and nonischemic injury in the mouse","volume":"66","author":"Marchetti","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbagen.2025.130800_bb0255","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbagen.2025.130800_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.04.022","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction","volume":"74","author":"Gao","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbagen.2025.130800_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.00037","article-title":"MCC950, a selective inhibitor of NLRP3 Inflammasome, reduces the inflammatory response and improves neurological outcomes in mice model of spinal cord injury","volume":"7","author":"Jiao","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1471-y","article-title":"A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury","volume":"16","author":"Kuwar","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbagen.2025.130800_bb0275","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.phrs.2017.10.008","article-title":"Apigenin as neuroprotective agent: of mice and men","volume":"128","author":"Nabavi","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbagen.2025.130800_bb0280","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejphar.2016.01.015","article-title":"Apigenin reverses depression-like behavior induced by chronic corticosterone treatment in mice","volume":"774","author":"Weng","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbagen.2025.130800_bb0285","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/carcin\/bgt316","article-title":"Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K\/Akt\/FoxO pathway","volume":"35","author":"Shukla","year":"2014","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.bbagen.2025.130800_bb0290","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3390\/biomedicines12061353","article-title":"Apigenin: A bioflavonoid with a promising role in disease prevention and treatment","volume":"12","author":"Allemailem","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbagen.2025.130800_bb0295","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bcp.2018.07.039","article-title":"Cardamonin, a natural flavone, alleviates inflammatory bowel disease by the inhibition of NLRP3 inflammasome activation via an AhR\/Nrf2\/NQO1 pathway","volume":"155","author":"Wang","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2025.130800_bb0300","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2016.11.009","article-title":"Cardamonin (2\u2032, 4\u2032-dihydroxy-6\u2032-methoxychalcone) isolated from Boesenbergia rotunda (L.) Mansf. inhibits CFA-induced rheumatoid arthritis in rats","volume":"794","author":"Voon","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0305","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cbin.11217","article-title":"Cardamonin induces G2\/M arrest and apoptosis via activation of the JNK\u2013FOXO3a pathway in breast cancer cells","volume":"44","author":"Kong","year":"2020","journal-title":"Cell Biol. Int."},{"issue":"2","key":"10.1016\/j.bbagen.2025.130800_bb0310","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3390\/biomedicines9020136","article-title":"Anti-NLRP3 inflammasome natural compounds: an update","volume":"9","author":"Liu","year":"2021","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.bbagen.2025.130800_bb0315","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/biomedicines8120586","article-title":"Cardamonin exerts antitumor effect on human hepatocellular carcinoma xenografts in Athymic nude mice through inhibiting NF-\u03ba\u03b2 pathway","volume":"8","author":"Badroon","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbagen.2025.130800_bb0320","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2016.11.009","article-title":"Cardamonin (2\u2032,4\u2032-dihydroxy-6\u2032-methoxychalcone) isolated from Boesenbergia rotunda (L.) Mansf. Inhibits CFA-induced rheumatoid arthritis in rats","volume":"794","author":"Voon","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0325","first-page":"265","article-title":"Luteolin alleviates NLRP3 inflamsome activation and directs macrophage polarization in lipopolysaccharide-stimulated RAW264.7 cells","volume":"10","author":"Zhang","year":"2018","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.bbagen.2025.130800_bb0330","first-page":"1","article-title":"Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment","volume":"10","author":"Ma","year":"2019","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bbagen.2025.130800_bb0335","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/aps.2016.142","article-title":"Luteolin-7-diglucuronide attenuates isoproterenol-induced myocardial injury and fibrosis in mice","volume":"38","author":"Ning","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbagen.2025.130800_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.119008","article-title":"Luteolin alleviates inflammation and modulates gut microbiota in ulcerative colitis rats","volume":"269","author":"Li","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bbagen.2025.130800_bb0345","doi-asserted-by":"crossref","first-page":"1114428","DOI":"10.3389\/fpain.2023.1114428","article-title":"Luteolin: A promising natural agent in management of pain in chronic conditions","volume":"4","author":"Ntalouka","year":"2023","journal-title":"Front. Pain Res."},{"key":"10.1016\/j.bbagen.2025.130800_bb0350","series-title":"Academia.EduCE Orji, CK Okpoko, CA Agbata, J Okoyeh, A Okeke, C IhekweremeJournal of Clinical Toxicology, 2020\u2022academia.Edu","article-title":"undefined. (n.d.). Evaluation of the effect of luteolin on the hepatic and hematopoietic systems in albino rats","author":"Orji","year":"2020"},{"key":"10.1016\/j.bbagen.2025.130800_bb0355","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6054069","article-title":"Artemisia extract suppresses NLRP3 and AIM2 inflammasome activation by inhibition of ASC phosphorylation","volume":"2018","author":"Kwak","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bbagen.2025.130800_bb0360","article-title":"The essential oil of Artemisia argyi H.L\u00e9v. And Vaniot attenuates NLRP3 Inflammasome activation in THP-1 cells","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbagen.2025.130800_bb0365","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5628601","article-title":"Artemisia spp.: an update on its chemical composition, pharmacological and toxicological profiles","volume":"2022","author":"Sharifi-Rad","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"8","key":"10.1016\/j.bbagen.2025.130800_bb0370","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.4049\/jimmunol.1701495","article-title":"Curcumin suppresses IL-1\u03b2 secretion and prevents inflammation through inhibition of the NLRP3 inflammasome","volume":"200","author":"Yin","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2025.130800_bb0375","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jad.2016.09.047","article-title":"Efficacy of curcumin, and a saffron\/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study","volume":"207","author":"Lopresti","year":"2017","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.bbagen.2025.130800_bb0380","first-page":"449","article-title":"Curcumin prevents osteoarthritis by inhibiting the activation of Inflammasome NLRP3","volume":"37","author":"Sun","year":"2017"},{"issue":"3","key":"10.1016\/j.bbagen.2025.130800_bb0385","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3233\/JAD-170512","article-title":"Protective effects of Indian spice curcumin against amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"61","author":"Reddy","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"10","key":"10.1016\/j.bbagen.2025.130800_bb0390","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.3390\/nu11102376","article-title":"Curcumin and Cancer","volume":"11","author":"Giordano","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.bbagen.2025.130800_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.01021","article-title":"Turmeric and its major compound curcumin on health: bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications","volume":"11","author":"Sharifi-Rad","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"49","key":"10.1016\/j.bbagen.2025.130800_bb0400","doi-asserted-by":"crossref","first-page":"80262","DOI":"10.18632\/oncotarget.12918","article-title":"Andrographolide ameliorates OVA-induced lung injury in mice by suppressing ROS-mediated NF-\u03baB signaling and NLRP3 inflammasome activation","volume":"7","author":"Peng","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.bbagen.2025.130800_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-2195-8","article-title":"Inhibition of AIM2 inflammasome-mediated pyroptosis by Andrographolide contributes to amelioration of radiation-induced lung inflammation and fibrosis","volume":"10","author":"Gao","year":"2019","journal-title":"Cell Death & Disease"},{"issue":"3","key":"10.1016\/j.bbagen.2025.130800_bb0410","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00705-016-3166-3","article-title":"Broad-spectrum antiviral properties of andrographolide","volume":"162","author":"Gupta","year":"2017","journal-title":"Arch. Virol."},{"issue":"11","key":"10.1016\/j.bbagen.2025.130800_bb0415","doi-asserted-by":"crossref","first-page":"8359","DOI":"10.1007\/s13277-015-3578-9","article-title":"Andrographolide radiosensitizes human ovarian cancer SKOV3 xenografts due to an enhanced apoptosis and autophagy","volume":"36","author":"Zhang","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbagen.2025.130800_bb0420","doi-asserted-by":"crossref","first-page":"6224107","DOI":"10.1155\/2022\/6224107","article-title":"Acute and subacute toxicity assessment of Andrographolide-2-hydroxypropyl-\u03b2-cyclodextrin complex via Oral and inhalation route of Administration in Sprague-Dawley Rats","volume":"2022","author":"Chandrama Singh","year":"2022","journal-title":"Sci. World J."},{"key":"10.1016\/j.bbagen.2025.130800_bb0425","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6137420","article-title":"Natural compound Oridonin inhibits endotoxin-induced inflammatory response of activated hepatic stellate cells","volume":"2018","author":"Cummins","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"8","key":"10.1016\/j.bbagen.2025.130800_bb0430","article-title":"Oridonin attenuates A\u03b21\u201342-induced Neuroinflammation and inhibits NF-\u03baB pathway","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2025.130800_bb0435","doi-asserted-by":"crossref","first-page":"7548","DOI":"10.12659\/MSM.912740","article-title":"Oridonin inhibits Myofibroblast differentiation and bleomycin-induced pulmonary fibrosis by regulating transforming growth factor \u03b2 (TGF\u03b2)\/Smad pathway","volume":"24","author":"Fu","year":"2018","journal-title":"Med. Sci. Monit."},{"issue":"6","key":"10.1016\/j.bbagen.2025.130800_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-1617-y","article-title":"Oridonin protects against cardiac hypertrophy by promoting P21-related autophagy","volume":"10","author":"Xu","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0445","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/13880209.2019.1674342","article-title":"The antibacterial mechanism of oridonin against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"57","author":"Yuan","year":"2019","journal-title":"Pharm. Biol."},{"issue":"3","key":"10.1016\/j.bbagen.2025.130800_bb0450","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbrc.2019.04.011","article-title":"ROS\/JNK\/c-Jun axis is involved in oridonin-induced caspase-dependent apoptosis in human colorectal cancer cells","volume":"513","author":"Zhang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bbagen.2025.130800_bb0455","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/molecules23020474","article-title":"Therapeutic potential of Oridonin and its analogs: from anticancer and Antiinflammation to neuroprotection","volume":"23","author":"Xu","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bbagen.2025.130800_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.557170","article-title":"Neuroprotective effect of Oridonin on traumatic brain injury via inhibiting NLRP3 Inflammasome in experimental mice","volume":"14","author":"Yan","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbagen.2025.130800_bb0465","article-title":"Oridonin: A review of its pharmacology, pharmacokinetics and toxicity","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbagen.2025.130800_bb0470","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.yexcr.2017.09.022","article-title":"X-11-5-27, a daidzein derivative, inhibits NLRP3 inflammasome activity via promoting autophagy","volume":"360","author":"Zhou","year":"2017","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-15314-8","article-title":"BOT-4-one attenuates NLRP3 inflammasome activation: NLRP3 alkylation leading to the regulation of its ATPase activity and ubiquitination","volume":"7","author":"Shim","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bbagen.2025.130800_bb0480","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/CS20160645","article-title":"BAY 11-7082 inhibits the NF-\u03baB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis","volume":"131","author":"Irrera","year":"2017","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-0980-9","article-title":"Targeting the NLRP3 inflammasome to attenuate spinal cord injury in mice","volume":"14","author":"Jiang","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.bbagen.2025.130800_bb0490","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.etap.2015.01.019","article-title":"BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-\u03baB pathway","volume":"39","author":"Kolati","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"20","key":"10.1016\/j.bbagen.2025.130800_bb0495","doi-asserted-by":"crossref","first-page":"11108","DOI":"10.3390\/ijms222011108","article-title":"NLRP3 inflammasome inhibitor BAY-117082 reduces oral squamous cell carcinoma progression","volume":"22","author":"Scuderi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"41","key":"10.1016\/j.bbagen.2025.130800_bb0500","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102975118","article-title":"Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degeneration","volume":"118","author":"Ambati","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bbagen.2025.130800_bb0505","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome\u2013mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.bbagen.2025.130800_bb0510","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.celrep.2017.02.004","article-title":"\u0392-Hydroxybutyrate deactivates neutrophil NLRP3 Inflammasome to relieve gout flares","volume":"18","author":"Goldberg","year":"2017","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-08055-1","article-title":"Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses","volume":"7","author":"Yamanashi","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbagen.2025.130800_bb0520","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.celrep.2018.09.058","article-title":"Salt-responsive metabolite, \u03b2-Hydroxybutyrate","volume":"25","author":"Chakraborty","year":"2018","journal-title":"Attenuates Hypertension. Cell Reports"},{"key":"10.1016\/j.bbagen.2025.130800_bb0525","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00172","article-title":"2-deoxyglucose and beta-hydroxybutyrate: metabolic agents for seizure control","volume":"13","author":"Rho","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbagen.2025.130800_bb0530","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2016.11.009","article-title":"Cardamonin (2\u2032, 4\u2032-dihydroxy-6\u2032-methoxychalcone) isolated from Boesenbergia rotunda (L.) Mansf. inhibits CFA-induced rheumatoid arthritis in rats","volume":"794","author":"Voon","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbagen.2025.130800_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1351-4","article-title":"Cardamonin inhibits breast cancer growth by repressing HIF-1\u03b1-dependent metabolic reprogramming","volume":"38","author":"Jin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bbagen.2025.130800_bb0540","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/annrheumdis-2016-209686","article-title":"Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)","volume":"76","author":"Kuemmerle-Deschner","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"03","key":"10.1016\/j.bbagen.2025.130800_bb0545","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1142\/S0192415X19500332","article-title":"Cardamonin induces cell cycle arrest, apoptosis and alters apoptosis associated gene expression in WEHI-3 mouse leukemia cells","volume":"47","author":"Liao","year":"2019","journal-title":"Am. J. Chin. Med."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0550","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jid.2019.05.025","article-title":"Glyburide, a NLRP3 inhibitor, decreases inflammatory response and is a candidate to reduce pathology in Leishmania braziliensis infection","volume":"140","author":"Carvalho","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"21","key":"10.1016\/j.bbagen.2025.130800_bb0555","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111640","article-title":"Glyburide suppresses inflammation-related colorectal tumorigenesis through inhibition of NLRP3 Inflammasome","volume":"25","author":"Maeda","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbagen.2025.130800_bb0560","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-26775-w","article-title":"MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice","volume":"8","author":"Perera","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bbagen.2025.130800_bb0570","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.4049\/jimmunol.1600035","article-title":"Efficacy and pharmacology of the NLRP3 Inflammasome inhibitor CP-456,773 (CRID3) in murine models of dermal and pulmonary inflammation","volume":"197","author":"Primiano","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2025.130800_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111442","article-title":"Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease","volume":"138","author":"Chen","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"21","key":"10.1016\/j.bbagen.2025.130800_bb0580","doi-asserted-by":"crossref","first-page":"9718","DOI":"10.1021\/acs.jmedchem.9b01155","article-title":"Discovery of second-generation NLRP3 Inflammasome inhibitors: design, synthesis, and biological characterization","volume":"62","author":"Jiang","year":"2019","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FJC.0000000000000247","article-title":"Pharmacologic inhibition of the NLRP3 inflammasome preserves cardiac function after ischemic and nonischemic injury in the mouse","volume":"66","author":"Marchetti","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbagen.2025.130800_bb0620","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s12035-017-0467-9","article-title":"NLRP3 inflammasome inhibitor ameliorates amyloid pathology in a mouse model of Alzheimer\u2019s disease","volume":"55","author":"Yin","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.bbagen.2025.130800_bb0635","article-title":"Flavonoid apigenin inhibits lipopolysaccharide-induced inflammatory response through multiple mechanisms in macrophages","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"issue":"355","key":"10.1016\/j.bbagen.2025.130800_bb0640","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.taap.2018.06.022","article-title":"Flavonoids interfere with NLRP3 inflammasome activation","author":"Lim","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0645","first-page":"1","article-title":"Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice","volume":"13","author":"Lu","year":"2023","journal-title":"Sci. Rep."},{"issue":"155","key":"10.1016\/j.bbagen.2025.130800_bb0655","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bcp.2018.07.039","article-title":"Cardamonin, a natural flavone, alleviates inflammatory bowel disease by the inhibition of NLRP3 inflammasome activation via an AhR\/Nrf2\/NQO1 pathway","volume":"1","author":"Wang","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2025.130800_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1351-4","article-title":"Cardamonin inhibits breast cancer growth by repressing HIF-1\u03b1-dependent metabolic reprogramming","volume":"38","author":"Jin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbagen.2025.130800_bb0660","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2016.11.009","article-title":"Cardamonin (2\u2032, 4\u2032-dihydroxy-6\u2032-methoxychalcone) isolated from Boesenbergia rotunda (L.) Mansf. inhibits CFA-induced rheumatoid arthritis in rats","volume":"794","author":"Voon","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbagen.2025.130800_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2021.112955","article-title":"Guaianolides from Artemisia codonocephala suppress interleukine-1\u03b2 secretion in macrophages","volume":"192","author":"Wang","year":"2021","journal-title":"Phytochemistry"},{"issue":"7","key":"10.1016\/j.bbagen.2025.130800_bb0690","first-page":"369","article-title":"Curcumin represses NLRP3 inflammasome activation via TLR4\/MyD88\/NF-\u03baB and P2X7R signaling in PMA-induced macrophages","author":"Kong","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-04673-x","article-title":"Attenuation of innate immunity by Andrographolide derivatives through NF-\u03baB signaling pathway","volume":"7","author":"Nie","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbagen.2025.130800_bb0710","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jaci.2022.05.029","article-title":"Spontaneous NLRP3 inflammasome-driven IL-1-\u03b2 secretion is induced in severe COVID-19 patients and responds to anakinra treatment","volume":"150","author":"Bertoni","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"issue":"46","key":"10.1016\/j.bbagen.2025.130800_bb0715","doi-asserted-by":"crossref","first-page":"75571","DOI":"10.18632\/oncotarget.12289","article-title":"IL-1 drives breast cancer growth and bone metastasis in vivo","volume":"7","author":"Holen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbagen.2025.130800_bb0720","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66125","article-title":"An open label trial of anakinra to prevent respiratory failure in COVID-19","volume":"10","author":"Kyriazopoulou","year":"2021","journal-title":"ELife"},{"issue":"12","key":"10.1016\/j.bbagen.2025.130800_bb0725","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with Canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"10105","key":"10.1016\/j.bbagen.2025.130800_bb0730","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bbagen.2025.130800_bb0585","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.bbagen.2025.130800_bb0590","article-title":"NLRP3 inflammasome activation in cancer: a double-edged sword","volume":"8","author":"Hamarsheh","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bbagen.2025.130800_bb0595","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.bbagen.2025.130800_bb0600","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3390\/molecules23030522","article-title":"Inhibiting the NLRP3 inflammasome activation with MCC950 ameliorates diabetic encephalopathy in db\/db mice","volume":"23","author":"Zhai","year":"2018","journal-title":"Molecules"},{"issue":"26","key":"10.1016\/j.bbagen.2025.130800_bb0605","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1016\/j.cell.2021.11.011","article-title":"NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation","volume":"184","author":"Andreeva","year":"2021","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bbagen.2025.130800_bb0615","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1021\/acs.jmedchem.8b00733","article-title":"Structural insights of benzenesulfonamide analogues as NLRP3 inflammasome inhibitors: design, synthesis, and biological characterization","volume":"61","author":"Fulp","year":"2018","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bbagen.2025.130800_bb0625","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP 3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol. Med."},{"issue":"2","key":"10.1016\/j.bbagen.2025.130800_bb0630","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/iej.13413","article-title":"MicroRNA-223 negatively regulates LPS-induced inflammatory responses by targeting NLRP3 in human dental pulp fibroblasts","volume":"54","author":"Wang","year":"2021","journal-title":"Int. Endod. J."},{"issue":"6","key":"10.1016\/j.bbagen.2025.130800_bb0670","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/annrheumdis-2016-209686","article-title":"Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)","volume":"76","author":"Kuemmerle-Deschner","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"03","key":"10.1016\/j.bbagen.2025.130800_bb0675","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1142\/S0192415X19500332","article-title":"Cardamonin induces cell cycle arrest, apoptosis and alters apoptosis associated gene expression in WEHI-3 mouse leukemia cells","volume":"47","author":"Liao","year":"2019","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.bbagen.2025.130800_bb0685","first-page":"1","article-title":"Arglabin could target inflammasome-induced ARDS and cytokine storm associated with COVID-19","volume":"1","author":"Manayi","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"8","key":"10.1016\/j.bbagen.2025.130800_bb0695","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.4049\/jimmunol.1701495","article-title":"Curcumin suppresses IL-1\u03b2 secretion and prevents inflammation through inhibition of the NLRP3 inflammasome","volume":"200","author":"Yin","year":"2018","journal-title":"J. Immunol."},{"issue":"20","key":"10.1016\/j.bbagen.2025.130800_bb0735","doi-asserted-by":"crossref","first-page":"11108","DOI":"10.3390\/ijms222011108","article-title":"NLRP3 inflammasome inhibitor BAY-117082 reduces oral squamous cell carcinoma progression","volume":"22","author":"Scuderi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bbagen.2025.130800_bb0740","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/ph16050640","article-title":"Association between fluoxetine use and overall survival among patients with Cancer treated with PD-1\/L1 immunotherapy","volume":"16","author":"Magagnoli","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbagen.2025.130800_bb0745","doi-asserted-by":"crossref","first-page":"13003","DOI":"10.2147\/CMAR.S279800","article-title":"Resatorvid relieves breast cancer complicated with depression by inactivating hippocampal microglia through TLR4\/NF-\u03baB\/NLRP3 signaling pathway","volume":"18","author":"Luo","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"8","key":"10.1016\/j.bbagen.2025.130800_bb0750","doi-asserted-by":"crossref","first-page":"702","DOI":"10.5152\/tjg.2021.191062","article-title":"\u0392-Hydroxybutyrate, one of the three main ketone bodies, ameliorates acute pancreatitis in rats by suppressing the NLRP3 inflammasome pathway","volume":"32","author":"Sahin","year":"2021","journal-title":"Turk J Gastroenterol"},{"issue":"14","key":"10.1016\/j.bbagen.2025.130800_bb0755","doi-asserted-by":"crossref","first-page":"1239025","DOI":"10.3389\/fphar.2023.1239025","article-title":"Unveiling the therapeutic potential of exogenous \u03b2-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis","volume":"28","author":"Abdelhady","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.bbagen.2025.130800_bb0760","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1002\/jcp.26331","article-title":"MicroRNA-22 suppresses cell proliferation, migration and invasion in oral squamous cell carcinoma by targeting NLRP3","volume":"233","author":"Feng","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"10.1016\/j.bbagen.2025.130800_bb0765","article-title":"MicroRNA post-transcriptional regulation of the NLRP3 inflammasome in immunopathologies","volume":"1","author":"Tezcan","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbagen.2025.130800_bb0770","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/iej.13413","article-title":"MicroRNA-223 negatively regulates LPS-induced inflammatory responses by targeting NLRP3 in human dental pulp fibroblasts","volume":"54","author":"Wang","year":"2021","journal-title":"Int. Endod. J."},{"issue":"11","key":"10.1016\/j.bbagen.2025.130800_bb0775","article-title":"Role of the NLRP3 inflammasome: insights into cancer hallmarks","volume":"3","author":"Lin","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0780","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12943-018-0900-3","article-title":"Role of the NLRP3 inflammasome in cancer","volume":"17","author":"Moossavi","year":"2018","journal-title":"Mol. Cancer"},{"issue":"236","key":"10.1016\/j.bbagen.2025.130800_bb0785","article-title":"Targeting the NLRP3 inflammasome in cardiovascular diseases","author":"Toldo","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbagen.2025.130800_bb0790","first-page":"15","article-title":"Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives","volume":"16","author":"Ozaki","year":"2015","journal-title":"J. Inflamm. Res."},{"issue":"11","key":"10.1016\/j.bbagen.2025.130800_bb0795","article-title":"NLRP3 inflammasome activation in cancer: a double-edged sword","volume":"8","author":"Hamarsheh","year":"2020","journal-title":"Front. Immunol."},{"issue":"145","key":"10.1016\/j.bbagen.2025.130800_bb0800","first-page":"55","article-title":"The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases","volume":"1","author":"Jiang","year":"2020","journal-title":"Adv. Immunol."},{"issue":"6","key":"10.1016\/j.bbagen.2025.130800_bb0805","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201847575","article-title":"The emerging roles of inflammasome-dependent cytokines in cancer development","volume":"20","author":"Van Gorp","year":"2019","journal-title":"EMBO Rep."},{"issue":"13","key":"10.1016\/j.bbagen.2025.130800_bb0810","doi-asserted-by":"crossref","first-page":"1007705","DOI":"10.3389\/fimmu.2022.1007705","article-title":"NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: from cryopyrin function to targeted therapies","volume":"6","author":"Moltrasio","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0815","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/acs.jmedchem.0c01307","article-title":"Strategies for targeting the NLRP3 inflammasome in the clinical and preclinical space","volume":"64","author":"Schwaid","year":"2020","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bbagen.2025.130800_bb0820","article-title":"The NLRP3 inflammasome: role and therapeutic potential in pain treatment","volume":"19","author":"Starobova","year":"2020","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.bbagen.2025.130800_bb0825","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbagen.2025.130800_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108545","article-title":"NLRP3 and cancer: pathogenesis and therapeutic opportunities","volume":"251","author":"Tengesdal","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0835","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12929-023-00983-7","article-title":"The \u2018speck\u2019-tacular oversight of the NLRP3-pyroptosis pathway on gastrointestinal inflammatory diseases and tumorigenesis","volume":"30","author":"Arr\u00e8","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbagen.2025.130800_bb0840","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.1007\/s13277-015-3473-4","article-title":"Differential expression of inflammasomes in lung cancer cell lines and tissues","volume":"36","author":"Kong","year":"2015","journal-title":"Tumour Biol."},{"issue":"4","key":"10.1016\/j.bbagen.2025.130800_bb0845","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/path.4357","article-title":"NLRPs, microbiota, and gut homeostasis: unravelling the connection","volume":"233","author":"Zambetti","year":"2014","journal-title":"J. Pathol."},{"issue":"9","key":"10.1016\/j.bbagen.2025.130800_bb0850","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1084\/jem.20160392","article-title":"S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3\/IL-1\u03b2","volume":"214","author":"Weichand","year":"2017","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bbagen.2025.130800_bb0855","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12105-024-01685-8","article-title":"Unravelling the significance of NLRP3 and IL-\u03b21 in Oral squamous cell carcinoma and potentially malignant Oral disorders: A diagnostic and prognostic exploration","volume":"18","author":"Jain","year":"2024","journal-title":"Head Neck Pathol."},{"issue":"5","key":"10.1016\/j.bbagen.2025.130800_bb0860","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1129484","article-title":"Linking cancer-induced Nlrp3 inflammasome activation to efficient NK cell-mediated immunosurveillance","volume":"5","author":"Dagenais","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbagen.2025.130800_bb0865","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-981-10-5987-2_6","article-title":"Inflammasomes in the gut mucosal homeostasis","author":"Yao","year":"2017","journal-title":"Regulat. inflammat. Signal. Health Disea."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416525000455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416525000455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T21:07:08Z","timestamp":1762290428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416525000455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":172,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0304416525000455"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2025.130800","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitors of inflammasome (NLRP3) signaling pathway as promising therapeutic candidates for oral cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2025.130800","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130800"}}